Discreviination between good and intermediate risk groups in acute myeloid leukemla, based on expression of HOX genes A5, B3, B5 and B6

M. Quinn, Mary Frances McMullin, F. Lopez, Alexander Thompson, T.R. Lappin

Research output: Contribution to journal › Article › peer-review

Cite this

@article{ad3aeaabda6142899095b3be2bce12c3,

title = "Discreviination between good and intermediate risk groups in acute myeloid leukemla, based on expression of HOX genes A5, B3, B5 and B6",

author = "M. Quinn and McMullin, {Mary Frances} and F. Lopez and Alexander Thompson and T.R. Lappin",

year = "2003",

month = jul,

language = "English",

volume = "31",

pages = "151--151",

journal = "Experimental Hematology",

issn = "1873-2399",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Discreviination between good and intermediate risk groups in acute myeloid leukemla, based on expression of HOX genes A5, B3, B5 and B6

AU - Quinn, M.

AU - McMullin, Mary Frances

AU - Lopez, F.

AU - Thompson, Alexander

AU - Lappin, T.R.

PY - 2003/7

Y1 - 2003/7

M3 - Article

SN - 1873-2399

VL - 31

SP - 151

EP - 151

JO - Experimental Hematology

JF - Experimental Hematology

ER -